Answer:
Answer is explained in the explanation section below.
Explanation:
Data Given:
Research and Development Cost = $10 million
Research Phase Cost = $6 million
Development Cost = $4 million
Total Sales of Product X are estimated at more than = $100 million
Solution:
a.
1. IFRS:
Research cost of $6 million have been expensed in year 1 in case of IFRS.
Whereas, for year 2 developmental cost is reported as assets and amortization is recorded on the asset which is the 5th part of the developmental cost of $4 million.
$4,000,000/5 = $800,000
2. U.S. GAAP:
Under U.S. GAAP in year 1, total of $10 million have been expensed including both research and development cost.
Under U.S. GAAP in year 2, however, there is no asset reported and all the costs are expensed in year 1 hence, no impact on the income statement.
b.
Income: In year 1 under IFRS, income will be higher by $4 million ($10-$6)million before the implication of tax.
But for year 2 to year 5:
In case of IFRS, income will be lowered due to the amortization on the deferred development cost. It will decrease by $800,000.
The total assets and stock holder's equity under IFRS will be higher by the following amounts each of the years.
Year 1 $4,000,000
Year 2 $3,200,000
Year 3 $2,400,000
Year 4 $1,600,000
Year 5 $800,000
The above amount is decreased by $800,000 each year because of the amortization of asset.
